Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

02 May 2003 : Original article  

Inhibition of poly (ADP-ribose) polymerase activity in vivo does not affect apoptosis induced by moderate g irradiation

L. Clarke, H. Louro, M. Silva, P. Costa, A. Ferro de Carvalho, M. Boavida

Med Sci Monit 2003; 9(1): 12-0 :: ID: 15059


The aim of this study was to test the effectiveness of two potent PARP inhibitors in vivo, and to measure their effect on cellular apoptosis and DNA breakage following a low level genotoxic insult in C57Bl/6 mice. Animals were injected intraperitoneally with either PBS vehicle, 3-aminobenzamide (3-AB) or 5-aminoisoquinolinone (5-AIQ). Half of the animals were then subjected to 3 Gy whole body g-irradiation, and sacrificed three hours later. PARP activity was measured in spleen, and was found to be significantly stimulated following g-irradiation. Neither 3-AB nor 5-AIQ displayed significant inhibitory effects in the absence of the genotoxic insult, but both modulated the rise in PARP activity induced by radiation, significantly in the case of 3-AB. Apoptotic index (AI) was assessed in histological sections of spleen and colon by TUNEL assay, but although irradiation induced a significant multiple-fold increase of AI in both tissues after 3 hours, this was not affected by the inhibitory actions of 3-AB or 5-AIQ. Furthermore, neither inhibitor affected the induction of reticulocyte micronuclei, a measure of chromosomal damage, 48 h after treatment in irradiated or unirradiated mice. Our data suggest that inhibitors of PARP activity used in vivo do not abolish residual activity present in resting tissues, but can effectively stifle an excess of activity induced by DNA strand breakage. However, we also conclude that this excess has no measurable effect on the associated increase in cellular apoptosis and chromosomal breakage.

Keywords: PARP, 3-aminobenzamide, 5-aminoisoquinolinone, g-irradiation, micronuclei

Add Comment 0 Comments


01 July 2024 : Editorial  

Editorial: The Global Threats of Increasing Antimicrobial Resistance Require New Approaches to Drug Development, Including Molecular Antimicrobial Adjuvants

Dinah V. Parums

DOI: 10.12659/MSM.945583

Med Sci Monit 2024; 30:e945583


In Press

Clinical Research  

Impact of Denture Use on Oral Health-Related Quality of Life in Yemeni Patients: A Cross-Sectional Analysis

Med Sci Monit In Press; DOI: 10.12659/MSM.944682  


Clinical Research  

Minimally Invasive versus Traditional Surgery: Efficacy of PELD and PLIF in Treating Pyogenic Spondylodiscitis

Med Sci Monit In Press; DOI: 10.12659/MSM.943176  

Clinical Research  

Frontal Plane Body Posture as a Predictor of Musculoskeletal Injuries in Amateur Athletes: A Comprehensive ...

Med Sci Monit In Press; DOI: 10.12659/MSM.944810  

Clinical Research  

Cost-Effectiveness Analysis of Hepatic Arterial Chemotherapy for Advanced Hepatocellular Carcinoma in China...

Med Sci Monit In Press; DOI: 10.12659/MSM.944526  

Most Viewed Current Articles

17 Jan 2024 : Review article   3,861,054

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799


14 Dec 2022 : Clinical Research   1,585,498

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990


16 May 2023 : Clinical Research   690,905

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387


01 Jan 2022 : Editorial   50,731

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952


Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750